HB 5074 changes how revenue from West Virginia's medical cannabis program is allocated. For fiscal year 2026, it directs $3 million to the Supreme Court for a child protection pilot, $10 million each to West Virginia University and Marshall University for ibogaine research, and $5 million to homelessness services, with remaining funds reverting to general revenue. Starting July 1, 2026, annual allocations will be: 15% to the Medical Cannabis Bureau for administration, 15% to the Department of Agriculture for cannabis testing, and 45% split among the Fight Substance Abuse Fund (20%), university research (10% each to Marshall and WVU), a Child Protection Commission (10%), and law enforcement training programs (40%). These changes apply to ongoing revenue from medical cannabis taxes, not new taxes or fees.
HB 4655 expands West Virginia's Laken's Law to require annual substance abuse education about fentanyl, heroin, and opioids for students in grades 3-12, instead of the current 6-12 range. The bill mandates that all public schools teach five specific topics annually, including awareness of opioids, use of opioid reversal agents, prevention of addiction, community resources, and health education on youth substance use. This expansion would take effect for grades 3-5 starting in the 2026-2027 school year, while the existing grades 6-12 requirement continues. The law directly affects all public school students in these grade levels through mandated classroom instruction.
HB 4451, the Veteran Justice Act, creates a program allowing eligible veterans charged with certain offenses to avoid a criminal conviction or have a felony reduced to a misdemeanor. It applies to veterans with military-related conditions like PTSD, TBI, or substance use disorder (SUD) that contributed to their offense, provided the crime is probation-eligible and not excluded (e.g., murder, sexual assault). Eligible veterans enter a court-supervised program involving evidence-based treatment tailored to their military service challenges, a personalized case plan, and probation instead of incarceration. If they successfully complete the plan, they avoid conviction; failure results in standard sentencing. The bill excludes serious crimes like human trafficking and requires verification of veteran status using federal databases like SQUARES.
HB 4196 requires licensed medication-assisted treatment (MAT) programs in West Virginia to offer long-acting reversible contraception (LARC), such as IUDs or implants, to patients receiving methadone or suboxone for substance use treatment. This applies to all facilities providing these services under the state's licensing framework, adding it as a standard requirement to existing operational rules. The bill directly affects MAT facilities, which must now integrate LARC options into their care protocols, and patients using methadone or suboxone at these locations. It creates a concrete policy change by mandating access to these contraceptive methods without requiring additional patient steps.
HB 4413 bans syringe exchange programs in West Virginia by making them unlawful under new law, requiring all existing programs to cease operations by the effective date. It allows harm reduction services (like overdose prevention education, naloxone distribution, and referrals to treatment) to continue without needle exchanges during a 120-day transition period for patient care. Operators who continue syringe exchanges after the effective date face daily civil penalties of up to $2,500, and the state health office can seek court orders to enforce the ban. The bill specifically prohibits offering sterile needles without a prescription, while permitting other health services that don’t involve syringe exchanges.
This bill establishes a value-based payment system for West Virginia's Medicaid addiction care services, shifting from fee-for-service to rewarding providers based on patient recovery outcomes. It directly affects Medicaid providers treating substance use disorders by requiring them to use standardized billing codes starting in 2027 and report on five specific outcome metrics: housing stability, sobriety, avoidance of criminal justice involvement, self-sufficiency (employment/education), and provider transition plans. The bill mandates data collection and analysis by the Bureau for Medical Services to develop these metrics, with value-based payments requiring implementation by 2028. The goal is to create a coordinated care system focused on long-term recovery success rather than fragmented service volume.
HB 4458, known as "Joel’s Law," creates a legal process for involuntary treatment of individuals with substance use disorders who pose an imminent danger to themselves or others. It requires a petition from a family member, friend, or guardian to a West Virginia Circuit Court, accompanied by a guarantee to cover treatment costs, and sets strict criteria: the person must have a substance use disorder, present an immediate danger, and be likely to benefit from treatment. The bill establishes a 72-hour emergency treatment option and a formal court process for 60- to 360-day treatment orders, including medical examinations and a hearing within 14 days. This law directly affects individuals meeting these specific danger criteria and their families, while ensuring procedural safeguards like court oversight and cost accountability.
HB 4032 would establish quick response teams (QRTs) under West Virginia's Office of Drug Control Policy to assist individuals with substance use disorders who are arrested and experiencing drug-related medical emergencies. These teams would provide immediate support and connect arrested individuals to treatment options at regional jails or treatment facilities, working directly with law enforcement and health services. The bill requires the Office of Drug Control Policy to develop this program by coordinating with health care providers, emergency services, and law enforcement, effective July 1, 2026. This policy change aims to create a direct pathway to recovery for people with substance use disorders following an arrest.
This bill (SB 35) limits employer liability when an employee's criminal record for drug addiction-related offenses or diseases is expunged. It requires the state to create a database tracking these expungements and mandates courts to check this database in cases involving such employees. Employers are not required to provide health insurance or cover health care costs related to drug addiction or addiction-related diseases if the employee's record was expunged. The law specifically applies to employees participating in "return to work initiatives" for recovering addicts and does not affect employers' obligations for non-addiction-related issues.
SB 361 authorizes the West Virginia Board of Pharmacy to implement a rule regarding pharmacist recovery networks, which are programs enabling pharmacists to provide medication-assisted treatment for opioid use disorder. The rule, previously drafted and modified to address legislative concerns, is now formally approved by law. This procedural bill directly affects pharmacists and pharmacies by allowing the Board to establish standards for participation in recovery networks. It does not alter the rule's content but enables its implementation as part of pharmacy practice regulations.
